John Ruckdeschel
Publications by Year
Research Areas
Selenium in Biological Systems, Lung Cancer Treatments and Mutations, Hepatocellular Carcinoma Treatment and Prognosis, Palliative Care and End-of-Life Issues, Cancer survivorship and care
Most-Cited Works
- → A Prospective Randomized Trial to Determine the Benefit of Surgical Resection of Residual Disease Following Response of Small Cell Lung Cancer to Combination Chemotherapy(1994)347 cited
- → Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers(2012)236 cited
- → Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non–Small-Cell Lung Cancer: ECOG 5597(2013)129 cited
- → RADIATION-RELATED PERICARDIAL EFFUSIONS IN PATIENTS WITH HODGKINʼS DISEASE(1975)75 cited
- → Cediranib, a VEGF receptor 1, 2, and 3 inhibitor, and pemetrexed in patients (pts) with recurrent non-small cell lung cancer (NSCLC)(2009)30 cited
- Chemotherapy for esophageal cancer with mitoguazone, methotrexate, bleomycin, and cisplatin.(1985)
- → APPLICATION OF LASER CYTOMETRY TO THE ANALYSIS OF IMMUNOLOGICALLY INDUCED IN VITRO LYMPHOCYTE RESPONSIVENESS(1977)6 cited
- → Advanced Cancer Detection Center(1999)
- → P-252 Interim report: A phase III randomized double blindchemoprevention trial of selenium supplementation in persons with resected stage I non small cell lung cancer(2005)
- A phase III randomized double blind chemoprevention trial of selenium supplementation in persons with resected stage I non small cell lung cancer: A year-six update.(2006)